ZAIVALIFESCIENCES
Duvastin 30 pharmaceutical pack by Zaiva Lifesciences

Neurology & Neuropathic Pain

Duvastin 30

Duloxetine · 30 mg

A serotonin–noradrenaline reuptake inhibitor with established roles in neuropathic pain and selected mood disorders.

BrandDuvastin 30
CompositionDuloxetine
Strength30 mg
Dosage formTablet

Overview

Neuropathic pain and other duloxetine indications according to the approved local label.

  • Serotonin–noradrenaline reuptake inhibition strengthens descending inhibitory pain pathways.
  • Duloxetine has established evidence in diabetic peripheral neuropathic pain.
  • The molecule also has established psychiatric and chronic-pain indications in several regulatory jurisdictions.

Composition & dosage

Composition: Duloxetine · 30 mg

Dosage form: Tablet

Dosage: As prescribed by the doctor.

How it works

SNRI: inhibits serotonin and norepinephrine reuptake; central pain-inhibitory and antidepressant effects are believed to relate to increased serotonergic/noradrenergic activity.

  1. SNRI: inhibits serotonin and norepinephrine reuptake
  2. central pain-inhibitory and antidepressant effects are believed to relate to increased serotonergic/noradrenergic activity.

Multiple randomized trials and systematic review evidence support duloxetine for painful diabetic peripheral neuropathy; antidepressant/anxiolytic evidence is separate and indication-specific.

Safety information

  • Monitor for nausea, dizziness, blood-pressure effects and serotonergic adverse reactions.
  • Consider hepatic disease, alcohol use and interacting serotonergic medicines.
  • Antidepressant-class warnings and discontinuation effects require attention.

Review the current approved prescribing information, contraindications, interactions, organ-function considerations, pregnancy/lactation advice and patient-specific risks before prescribing.

Evidence context

Multiple randomized trials and systematic review evidence support duloxetine for painful diabetic peripheral neuropathy; antidepressant/anxiolytic evidence is separate and indication-specific.

Dose-response, tolerability, blood pressure, hepatic risk and concomitant serotonergic medicines need individual review.